How Deep Brain Stimulation Aids Individuals Facing Parkinson's Disease
.jpg){kind=tracking}
New research suggests that deep brain stimulation remains effective in the long term for individuals with advanced Parkinson's disease. While deep brain stimulation has proven to be a successful therapy for Parkinson's, its long-term efficacy compared to medications was previously unknown. Although there is no known cure for Parkinson's, ongoing research continues to explore potential treatments.
Recent research from Germany indicates that deep brain stimulation could positively impact the quality of life for those with advanced Parkinson's disease. The University of Cologne conducted a study comparing two groups of people with Parkinson's disease: one group treated with deep brain stimulation of the subthalamic nucleus and another treated with standard-of-care medication.
After a 5-year follow-up period, researchers found that the quality of life remained stable in the group treated with deep brain stimulation, while the group receiving standard-of-care medication experienced a decline in quality of life. The findings, published in the medical journal JAMA, support the notion that deep brain stimulation is an effective therapy for individuals diagnosed with Parkinson's disease.
Parkinson's disease primarily affects the brain, with symptoms manifesting in various parts of the body. Motor symptoms, originating in the brain when midbrain nerve cells die off, can significantly impact an individual's daily life. Dr. David Charles, a professor and vice chair of neurology, explained that while the cause of typical Parkinson's disease remains a mystery, the degeneration of dopaminergic neurons in the brain makes deep brain stimulation a viable treatment.
Deep brain stimulation, approved by the U.S. Food and Drug Administration in 1997, remains a widely used standard therapy for Parkinson's disease. Dr. Charles emphasized the therapy's well-documented effectiveness, with major commercial insurances covering its usage.
The recent German study focused on individuals with advanced Parkinson's disease, offering valuable insights into the long-term benefits of deep brain stimulation. Dr. Jean-Philippe Langevin, a neurosurgeon and director of the Restorative Neurosurgery and Deep Brain Stimulation Program, praised the study as important and rigorous. The research addressed the question of whether deep brain stimulation would maintain its superiority in the long term, showcasing that it indeed led to better motor performance and maintained quality of life for patients.
While deep brain stimulation provides hope for individuals with Parkinson's, it's crucial to recognize that Parkinson's is a debilitating condition with no known cure. Symptoms worsen over time, impacting a person's ability to engage in regular activities. A Parkinson's diagnosis may necessitate assistance with basic daily tasks, making support from family, friends, and loved ones essential.
Despite the mysteries surrounding the causes of Parkinson's disease, ongoing research explores genetic influences, gene therapy, and cell-based therapy as potential treatments. Dr. Charles emphasized the positive news for newly diagnosed individuals, highlighting the availability of therapies and robust research efforts underway.
parkinsonism vs parkinson's disease, apokyn, cure for parkinson's disease, is parkinson's a neurological disorder, deep brain stimulation cost, corea de huntington, deep brain stimulation for parkinson's disease
A captivating read from start to finish.
ReplyDelete